Follow the money: medical technologies funded in January 2014

In descending order in the amount of funding received by the developing company, below is a list of the technologies in development at companies funded in January 2014:

  • Device-based and other treatments for glaucoma
  • Gel stent treatment for glaucoma
  • Tissue-based vascular grafts and other regenerative medicine products
  • Aesthetics products
  • Minimally invasive treatment for sinusitis
  • Cryotherapy for tissue ablation of multiple pathology types
  • Diagnostic monitoring technology with applications including medication adherence, oximetry, glucose monitoring and others
  • Heat-activated liposomal drug delivery for treatment of cancer
  • Device treatment for venous reflux related to formation of varicose veins
  • Laser for cataract surgery
  • Renal denervation via radiofrequency ablation for the treatment of hypertension
  • Absorbable surgical adhesives and sealants
  • Minimally invasive spine technologies including interspinous fusion
  • Ophthalmology prescreening device for diagnosis of major vision disorders
  • Peptide-mediated, in vivo cancer imaging
  • Device to expedite orthodontic treatment
  • Catheter-based endoscopic devices for the diagnosis of gastrointestinal cancers
  • Surgical skin closure devices
  • Convection-enhanced drug delivery to enable crossing the blood brain barrier in CNS conditions
  • Optical coherence tomography for skin cancer diagnosis
  • Electromagnetic navigation bronchoscopy for early detection of lung cancer
  • Devices for single incision laparoscopy
  • Low energy treatment for atrial fibrillation
  • Hip fracture fixation
  • Transcranial magnetic stimulation for treatment of migraine
  • Diagnosis and treatment of cardiac arrhythmias
  • Laparoscopic monopolar electro-surgical instruments
  • Device for the treatment of obstructive sleep apnea
  • Devices used for positioning in hip arthroplasties
  • Wireless implantable microelectronic lumbar spine fusion sensor
  • Neurosurgery instrumentation
  • Light-based cancer detection and diagnosis
  • Technology to detect cancer cells remaining following surgery
  • Diagnostic test systems for point-of-care use
  • Coil embolization and occlusion in endoluminal procedures
  • Interbody fusion device
  • Burn, wound and skin care products

For the companies and their funding amounts, see link.